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An alanine expanded PABPN1 causes increased utilization of
intronic polyadenylation sites
Tooba Abbassi-Daloii1, Soheil Yousefi1, Eleonora de Klerk2,3, Laurens Grossouw1, Muhammad Riaz1, Peter A. C. ’t Hoen1 and Vered Raz1
In eukaryote genomes, the polyadenylation site marks termination of mature RNA transcripts by a poly-adenine tail. The
polyadenylation site is recognized by a dynamic protein complex, among which the poly-adenine-binding protein nuclear1 plays a
key role. Reduced poly-adenine-binding protein nuclear1 levels are found in aged muscles and are even lower in oculopharyngeal
muscular dystrophy patients. Oculopharyngeal muscular dystrophy is a rare, late onset autosomal dominant myopathy, and is
caused by an alanine expansion mutation in poly-adenine-binding protein nuclear1. Mutant poly-adenine-binding protein nuclear1
forms insoluble nuclear aggregates leading to depletion of functional poly-adenine-binding protein nuclear1 levels. In
oculopharyngeal muscular dystrophy models, increased utilization of proximal polyadenylation sites has been observed in tandem
3′-untranslated regions, and most often cause gene upregulation. However, global alterations in expression profiles canonly partly
be explained by polyadenylation site switches within the most distal 3′-untranslated region. Most poly-adenine signals are found at
the distal 3′-untranslated region, but a significant part is also found in internal gene regions, like introns, exons, and internal 3′-
untranslated regions. Here, we investigated poly-adenine-binding protein nuclear1’s role in polyadenylation site utilization in
internal gene regions. In the quadriceps muscle of oculopharyngeal muscular dystrophy mice expressing expPABPN1 we found
significant polyadenylation site switches between gene regions in 17% of genes with polyadenylation site in multiple regions (N =
574; 5% False Discovery Rate). Polyadenylation site switches between gene regions were associated with differences in transcript
expression levels and alterations in open reading frames. Transcripts ending at internal polyadenylation site were confirmed in
tibialis anterior muscles from the same mice and in mouse muscle cell cultures overexpressing expPABPN1. The polyadenylation
site switches were associated with nuclear accumulation of full-length transcripts. Our results provide further insights into the
diverse roles of poly-adenine-binding protein nuclear1 in the post-transcriptional control of muscle gene expression and its
relevance for oculopharyngeal muscular dystrophy pathology and muscle aging.
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INTRODUCTION
The maturation of a messenger RNA (mRNA) is a multistep process
influencing the RNA landscape of a cell. Polyadenylation is an
essential step in mRNA maturation, affecting mRNA stability,
nuclear export, and translation efficiency.1 Polyadenylation
includes endonucleolytic cleavage of mRNA at the polyadenyla-
tion site (PAS) and is completed by addition of an adenine tail. The
majorityof genes have multiple PASs, generating distinct tran-
scripts.2 The majority of PASs are located in the distal 3′-
untranslated region (3′-UTR) and alternative PAS in the distal 3′-
UTR most often result in transcripts with a shorter 3′-UTR,
suggesting to affect mRNA stability.3 Although PASs are most
abundant in the distal 3′-UTR, polyadenylation within internal
gene regions (introns, exons, and internal 3′-UTRs) were also
found.2, 4 Genes with PASs in internal gene regions could generate
a wide range of alternative transcripts, among those with
alternative coding sequence (CDS).5
Polyadenylation is regulated by a dynamic protein complex and
the poly-adenine (poly(A))-binding protein nuclear 1 (PABPN1)
plays a central role.6 PABPN1 is ubiquitously expressed and is
primarily recognized for regulation of the poly(A) tail length.7
PABPN1 regulates PAS utilization in the distal 3′-UTR by
suppressing proximal PASs.8, 9 Reduced levels of functional
PABPN1 are found in aged muscles and in muscles from
oculopharyngeal muscular dystrophy (OPMD) patients.10 OPMD
is caused by an alanine expansion at the N-terminus of PABPN1
(expPABPN1).11 ExpPABPN1 forms insoluble aggregates in myo-
nuclei,12 which reduces levels of soluble PABPN1 (ref. 13). Reduced
levels of functional PABPN1 cause switches in PAS utilizationin the
distal 3′-UTR, with most prominent switches from distal to
proximal PAS 3′-UTR.8, 9 Shorter transcripts lead to a loss of
microRNA (miRNA)-binding sites, which could generally explain
upregulation of shorter transcripts from proximal PAS.8 More
recently, Li et al.,5 suggested a role for PABPN1 in internal PAS
utilization. Yet, this was not investigatedin the context of disease.
In this study, we investigated a role for expPABPN1 in PAS
utilization in internal gene regions in muscles. We employed our
previously generated genome-wide single molecule polyA-Seq
data9 where dealt only with PAS switches within the same 3′-UTR
region. Here, we extended PAS analysis across the genome and
found internal PASs in a quarter of muscle genes. We show that
changes in PAS utilization between gene regions occur in both
upstream and downstream directions (Fig. 1). The expPABPN1-
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induced PAS switches are associated with few non-canonical PAS
motifs. We show that PAS switches in genes involved in muscle
pathologies are affected by expPABPN1 expression. Our study
suggests that the role of PABPN1 in regulation of mRNA
processing is broad and can contribute to muscle weakness in
OPMD via different mechanisms.
RESULTS
Polyadenylation within gene regions is affected by expPABPN1 in
muscles
To investigate the effect of expPABPN1 on PAS usage in internal
gene regions we employed our previously generated single
molecule polyA sequencing data from the mouse quadriceps
muscles of A17.1 mice expressing expPABPN1 and their matched
wild-type FVB controls.9 Only PASs with coverage of at least two
reads per PASs in at least 6 out of 12 samples were included in the
analysis, leaving 35,351 PASs located in 13,685 genes. Confirming
previous studies,8, 9 the majority of PAS (69%) mapped to the
most distal 3′-UTR region, and the rest (31%; Fig. 2a) mapped into
internal gene regions, including introns, exons, and internal 3′-
UTRs. Three-thousand two-hundred and ninety six genes (24%)
contained PASs in multiple regions (Fig. 2b), and those were used
to investigate a role for expPABPN1 in PAS utilization in internal
regions.
In our previous study, we reported the effect of expPABPN1 on
PAS utilization in the distal 3′-UTR region (PASs in distal 3′-UTR).
To investigate expPABPN1 effect on internal PAS utilization, PAS
reads within a gene region were summed and the relative usage
of the different PAS regions were assessed with a generalized
linear mixed model on the binomial distribution of the counts for
each region in a gene. Per gene, a PAS region that was more used
in FVB control compared to A17.1 is dubbed as a default region,
and a PAS region that was more used in A17.1 compared to FVB is
referred to as a switch region.
The possible switches in PAS utilization could be from a default
distal PAS to an upstream PAS (named here an upstream switch)
or from a default PAS in internal region to a downstream PAS
(named here a downstream switch) (Fig. 1). Examples of upstream
and downstream switches are shown in Fig. 3. In 2300009A05Rik
(shortened here to RikA05), the default distal PAS was located in
the distal 3′-UTR and a secondary PAS was found within the intron
(Fig. 3a; FVB). The PAS within the intronic region was relatively
more utilized in A17.1 compared to FVB (Fig. 3a), indicating an
upstream switch. In Arih1, additionally to the previously described
PAS switch within the 3′-UTR,9 a PAS was found within an intron,
which was relatively more utilized in FVB. In A17.1 the PAS in the
distal 3′-UTR was relatively more utilized, indicating a downstream
switch (Fig. 3b).
From the 3296 genes with two or more PAS regions, 17%
showed a significant switch in PAS utilization between regions (N
= 574; false discovery rate (FDR) < 0.05; Fig. 3c). An upstream
switch was found in 66% of those genes (Fig. 3c; list in
Supplementary Table S2).
PASs within gene regions affect gene expression levels
Within the same 3′-UTR, switches from distal to proximal PAS
predominantly affect mRNA stability leading to transcript upre-
gulation.8, 9 Here, we investigated whether PAS utilization
between gene regions also affects mRNA expression levels. For
each gene fold changes were determined (Supplementary
Table S2), and we found that gene dysregulation was significantly
higher in genes with a PAS switch between gene regions
compared to genes without a switch (50% and 28%, respectively;
Fisher’s exact test p-value = 8.2E10-12) (Fig. 4a). The majority of
genes (66%) with PAS switch were found to be upregulated
(Fig. 4a). We then examined whether PAS switch direction
specifically affect gene dysregulation direction, and found in
genes with a downstream switch a slightly higher proportion of
dysregulated genes compared with an upstream switch (56.5%
and 46%, respectively).
Fig. 1 Schematic representation of PAS switches. Switches in PAS utilization are shown with arrows: upstream switches are depicted in blue
and downstream switches in red. An upstream switch is most often from distal 3′-UTR to any internal gene regions (intron, exon, and internal
3′-UTR), and a downstream switch is most often from any internal gene regions to distal 3′-UTR. Switches between tandem PASs in the distal
3′-UTR are also shown. The most prominent switches are depicted with continues line. PASs are depicted with vertical bars, the gene regions,
exon (E), intron (I), and 3′-UTR are indicated. Illustrated are the most abundant switch possibilities
Fig. 2 Distribution of PAS locations. a Pie chart showing the percentage of PASs distribution in different regions of the gene (24,248; 6273;
3106, and 1724 PASs located at distal 3′-UTRs, introns, exons, and internal 3′-UTR, respectively). b Pie chart showing the percentage of genes
containing PAS in single or multiple regions (3296 genes have multiple PAS regions and 10,355 genes have single PAS region)
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We further investigated whether switches to distinct gene
regions may affect dysregulation direction. As expected, PAS
switches to/from the distal 3′-UTR were predominant (78%)
(Fig. 4b). In internal gene regions PAS switches from/to introns
was the most abundant (Supplementary Table S3). The majority
PAS switches were upstream (66%) compared with a downstream
switch (34%). In both switch direction, the proportion of
upregulated genes was higher compared with downregulation,
but in the downstream switch relatively more genes had
upregulation compared with the upstream switch (77% and
59%, respectively). Notably, an upstream switch from distal 3′-UTR
to internal gene regions was not associated with a specific
dysregulation direction (Fig. 4b). Thus, in contrast to upstream PAS
switches within the 3′-UTR, which predominantly lead to increase
in transcript levels, an upstream switch between 3′-UTR and
introns or other gene regions doesnot specifically affect dysregu-
lation direction.
To validate PAS switches between gene regions that were
found in quadriceps muscles, reverse transcription quantitative
PCR (RT-qPCR) was performed on RNA from tibialis anterior
muscles, which are severely affected in A17.1 mouse.14 PAS
switches between gene regions were validated in six genes
containing one distinct PAS per gene region. Arih1 represents a
downstream switch, whereas RikA05, Vezf1, Lmna, Figf, and Ttn
genes represent an upstream switch (Fig. 5a). Usp19 was selected
as control as it possesses internal and distal PASs without switch in
utilization in A17.1 (Fig. 5a). We first confirmed the expression of
transcripts from internal PAS using a primer set specific to the
internal 3′-UTR or intronic region (Supplementary Fig. S3). PAS
usage in intronic regions resulted in alternative transcripts for
RikA05, Vezf1, Figf, and Arih1 transcripts (Supplementary Fig. S3).
Alternative transcripts from internal 3′-UTR region were found for
Lmna and Usp19 (Supplementary Fig. S3). The intronic region near
PAS in Ttn was not suitable for qRT-PCR, and the proximal primer
set was, therefore, designed on the nearby exon (Supplementary
Fig. S2). PAS switch was assessed by the ratio of PCR products
from the internal region and the distal 3′-UTR. In accordance with
the polyA-Seq data, we found a downstream switch between
internal PAS and distal PAS for Arih1 and an upstream switch for
RikA05, Lmna, Figf, and Ttn (Fig. 5b). For Vezf1 only a trend
suggesting an upstream switch was found (Fig. 5b). As expected,
no switch in PAS utilization was found for Usp19 (Fig. 5b). For
those seven genes we then also assessed whether PAS switch is
accompanied by a change in expression levels. Overall, fold
change direction was found to be consistent between RNA-seq
and qRT-PCR for 6 out of the 7 genes (Arih1, RikA05, LmnA, Figf,
Fig. 3 Upstream and downstream switches in PAS regions. a–b USCS Genome Browser screenshots displaying PASs in RikA05 (upstream
switch) and Arih1 (downstream switch) genes. The y-axis represents the coverage of the peaks, corresponding to the number of reads mapped
at each PAS. One of the FVB control and A17.1 mice are depicted in independent traces. PASs are depicted by arrows; distal or internal PASs are
indicated. The gene structure based on Ensembl annotation is presented in red. The amplified regions that were used for validation are
indicated below the gene structure; c Pie chart on left side shows the percentage of genes with changes in PAS utilization region (567 genes)
and the right pie chart shows the percentage of genes with downstream or upstream switches in PAS utilization (193 and 374 genes,
respectively)
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Ttn, and Usp19; Fig. 5c, d). Only for Vezf1 fold change was not
validated using qRT-PCR (Fig. 5c, d). Among the five genes with a
downstream switch in three genes upregulation and in two genes
downregulation was found in A17.1.
To confirma role of expPABPN1 in intronic PAS utilization, we
performed qRT-PCR in the IM2 muscle cell culture model for
OPMD. In this model, wild-type PABPN1 (WT) or expPABPN1 were
stably overexpressed at similar levels.13 Significant switches
between gene regions were found for 4 out of the 5 genes
(Fig. 6a). Switch direction was similar between the muscle cell
culture and muscles for RikA05 and Vezf1,and Arih1, but the fold
change was smaller in the cell culture model (Fig. 6a). In Lmna a
downstream switch, instead of an upstream switch, was found
(Fig. 6a). No PAS switch was found in Figf, and PAS switch also
remained unchanged in Usp19 (Fig. 6a). Ttn was excluded from
this study, since the intronic region near PAS could not be
amplified. Together those results further support a role for
expPABPN1 in PAS switch between regions.
Nuclear export of transcripts is affected by expPABPN1
PABPN1 shuttles between the nuclear and cytoplasm, and
expPABPN1 has a higher nuclear accumulation compared with
its wild-type counterpart.15 A higher nuclear accumulation of
expPABPN1 compared with WT PABPN1 was also found in the
Fig. 4 Differential expression analysis in upstream and downstream
switch groups. Bar chart shows differential expression analysis in
genes with or without a significant switch in PAS utilization (a) and
in genes with upstream or downstream switches (b). The number of
genes for each category is indicated
Fig. 5 PAS switch between regions in quadriceps and tibialis
anterior muscles. a Bar chart shows the ratio between distal to
internal PAS obtained from read counts from polyA-sequencing in
quadriceps muscle. Expression values were obtained after TMM
normalization. Averages and SD are from six mice. b Bar chart shows
the ratio between distal to internal PAS obtained from qRT-PCR
analysis in tibialis anterior muscle. Averages and SD are from six
mice. p-values for the differences between A17.1 and WT tibialis
anterior muscles were assessed with the Student’s t-test. Red outlines
depict a downstream switch, and blue outlines an upstream switch
Fig. 6 The effect of expPABPN1 on PAS utilization in muscle cell
culture. a Bar chart shows the ratio between distal and internal PAS
from qRT-PCR analysis. Red outlines are depicted for a downstream
switch, and blue outlines for an upstream switch and unchanged by a
black line. b Bar chart shows changes in transcript abundance
between nuclear and cytoplasmic fractions. Primer set amplifying
intronic regions are depicted by green outlines and from primer set
in the distal 3′-UTR by purple outlines. Averages and SD are from
three biological replicates. Differences between WT-PABPN1 and
expPABPN1 cultures were assessed with the Student’s t-test.
Significant p-values are in bold
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stable IM2 cell model.13 To assess whether subcellular distribution
of transcripts from internal or distal 3′-UTRPAS is affected by
nuclear retention of expPABPN1, the ratio between nuclear and
cytosolic abundance of transcripts from distal or proximal PAS was
investigated using qRT-PCR. RNA levels were normalized to Hprt
whose levels were similar in both fractions and expression levels
were unaffected by expPABPN1 expression (Fig. 6c). In 5 out of the
6 genes (Arih1, RikA05, Vezf1, Lmna, Usp19) the nuclear to
cytoplasmic ratio was affected by expPABPN1 expression (Fig. 6c).
Most consistently, the transcript from distal 3′-UTR showed a
higher nuclear accumulation in expPABPN1 expressing cells
compared with WT-PABPN1 cell cultures (Fig. 6c). Nuclear
accumulation of transcripts from proximal PAS was reduced in
expPABPN1 cell culture for Arih1 and RikA05 but was increased in
Lmna and Usp19 (Fig. 6c). High nuclear accumulation could
suggest aberrant nuclear export of transcripts or higher mRNA
decay in the cytoplasm. Our results suggest that nuclear
accumulation of transcripts from distal PAS is associated with
nuclear retention of expPABPN1. Nuclear accumulation of
transcripts from distal PAS was also confirmed in A17.1 tibialis
anterior muscles (Supplementary Fig. S5).
Polyadenylation signal motifs utilization is associated with
expPABPN1
Previously, we showed that in the distal 3′-UTR the non-canonical
polyadenylation signals are more frequently utilized when
expPABPN1 is expressed. The non-canonical polyadenylation
signals are found near proximal PASs in the distal 3′-UTR, whereas
the canonical polyadenylation signals (AATAAA and ATTAAA) are
mostly present near distal PASs in the distal 3′-UTR.9 Here, we
investigated whether any of the 2 canonical and 11 non-canonical
motifs were associated with expPABPN1-mediated PAS switches.
We counted the 13 polyadenylation signal motifs < 50 upstream of
the identified PAS, and assessed their frequencies in gene regions
demonstrating a PAS switch. The frequency of the motifs was
investigated separately in upstream or downstream regions and
default or switch regions and was compared with frequencies in
Fig. 7 Utilization of polyadenylation signal motifs in switch regions. a Density histograms of p-values of PAS motif distribution in switch or
default PAS regions. Analysis was stratified for downstream and upstream switches. In each group motif frequency was compared to the
frequency of all PASs, and statistical significance was assessed with Pearson’s chi-square test. p-values obtained by comparing between motifs
distribution in 1000 random subsets of PASs and motifs distribution of all PASs. The red line shows the calculated p-value for each group. b The
ratio between switch (A17.1) and default (FVB) PAS utilization regions for 13 polyadenylation signal motifs. Numerical values are shown in
Supplementary Table S4. Downstream or upstream switches are depicted by open circles or closed squares, respectively. Hashed line marks ratio
= 1. Canonical motifs are underlined. Arrows mark motifs with consistent switches in A17.1 mice: up arrows represents more utilized in A17.1
and down arrow less utilized in A17.1. c Bar chart shows the proportion of genes with up/down or unchanged expression in each PAS motif
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random selections from the identified PAS (Fig. 7a and
Supplementary Table S4). Only the motif frequencies in PAS in
downstream switch regions were found to be significantly
different from the randomly selected PAS (p-value = 0.003; chi-
square test; Fig. 7a).
To identify the specific polyadenylation signal motifs associated
with expPABPN1 expression, we analysed the differences between
the frequencies in the switch and default regions for each motif
separately. In five non-canonical motifs, we found a consistent
effect in both up- and downstream switches: AATATA, AATACA,
GATAAA, and AATAGA motifs were more utilized in A17.1,
whereas AAGAAA was less utilized in A17.1 (Fig. 7b). In six
polyadenylation signal motifs switch to default PAS utilization was
affected in A17.1, but this was not consistent between down-
stream and upstream switches (Fig. 7b). The CATAAA motif
utilization was markedly decreased by downstream. PAS utiliza-
tion in two motifs, including the major canonical motif AATAAA,
was not affected in A17.1 (Fig. 7b). Together this suggests that few
PAS motifs are associated with switch direction, and others are
not.
We then also investigated whether motifs are associated with
changes in expression. Gene dysregulation was found to be
significantly higher across all motifs (p = 0.007; chi-square test).
Higher proportion of upregulated genes was found for AATAAA,
ATTAAA, AATGAA, AATACA, and GATAAA motifs, whereas a higher
proportion of downregulated genes was found dysregulation was
found for AAGAAA and ACTAAA motifs (Fig. 7c). Overall,
comparing between switch directions and dysregulation direc-
tions per motif a clear consensus was not found. This suggests
that gene dysregulation is associated with PAS motifs but not with
PAS switch direction.
DISCUSSION
Levels of functional PABPN1 are reduced in aged muscles and to a
greater extent in OPMD muscles.10 The expanded PABPN1 is
prone to aggregation leading to depletion of the soluble
protein.13 Previous studies, including ours, demonstrated a
regulatory role for PABPN1 in alternative PAS in the distal 3′-
UTR.8, 9, 16 Although PASs are most abundant in the 3′-UTR, here
we show that in skeletal muscles PAS reads in internal gene
regions were found in one quarter of the genes. Most of the PASs
in internal gene regions are mapped to introns. We demonstrate
that expPABPN1 also alters PAS utilization between internal gene
regions. This indicates that expPABPN1 effect on mRNA proces-
sing is not limited to the distal 3′-UTR, and implies that the
spectrum of alternative transcripts in OPMD is broader than
shortening of transcripts at the distal 3′-UTR. Our study
demonstrates that expPABPN1-mediated switches in PAS utiliza-
tion between gene regions affect not only expression levels in
general but also the levels of transcripts variants with different
open reading frames (ORFs). We suggest that PAS switches
between gene regions potentially contribute to altered muscle
homeostasis as a consequence of expPABPN1 expression.
Upstream PAS switches within the distal 3′-UTR result in shorter
transcripts and generally upregulation of gene expression.8, 9
Transcripts from proximal PAS in the 3′-UTR could lose regulatory
elements, like miRNA-binding sites, and lead to increase in
transcript levels.8, 17, 18 Here, we show that downstream switches
between gene regions are predominantly associated with gene
upregulation. However, gene upregulation was mostly found in
the downstream switches, whereas upstream switches were not
associated with dysregulation direction. This suggests that PAS
switches between gene regions may alter the nature of the coding
sequence rather than expression levels. Since most PAS switches
were found from/to introns, it is possible that those alternative
transcripts could result in altered ORFs and/or non-sense
transcripts.
Among the genes with PAS switch between gene regions we
identified muscle genes that are associated with muscular
disorders like Dmd, Lmna, Ttn, Ano5, and Sgcb (Supplementary
Table S3). It is possible that altered transcript levels of those genes
may contribute to muscle weakness in OPMD. Since PABPN1 levels
are also reduced in muscles of the elderly,19 it is possible that
those altered transcripts also contribute to sarcopenia. In
agreement, complete knockdown of PABPN1 in cell culture also
leads to internal PAS utilization.5 In addition to alterations in
transcript levels, usage of PASs within internal gene regions could
generate alternative transcripts with alternative coding sequences
or be associated with lower levels of intact proteins and/or
production of truncated proteins. This may also contribute to
lower muscle strength in OPMD.
Increased internal PAS usage may be explained by changes in
the rate of splicing, alternative or incomplete splicing (intron
retention).20 Alternative splicing is regulated by the spliceosome
ribonucleoprotein complex.21 Although PABPN1 is not considered
as a splicing factor, a regulatory role for PABPN1 in splicing was
first suggested in non-muscle cells.22 More recently, it was
demonstrated that splicing of intron 15 of Troponin T3 (TNNT3)
is affected in OPMD muscle cells and can be regulated by PABPN1
expression levels.23 In our study, we found an upstream switch in
Tnnt3 (Supplementary Fig. S4). This supports alternative splicing in
Tnnt3 in A17.1 quadriceps muscles. However, our PolyA-Seq data
reveals internal PAS in several exons and introns in Tnnt3. A PAS
was found in intron 15 in the A17.1, but the most significant
switch was found in intron 14 (Supplementary Fig. S4). Addition-
ally, we found intronic PAS in A17.1 of Clcn1 gene (Supplementary
Fig. 4). CLCN1 mis-splicing causes delayed muscle relaxation
(myotonia) in Myotonic dystrophy 1 (ref. 24). This suggests that a
switch is PAS utilization possibly cause altered polypeptides in
genes regulating muscle contraction, and this can contribute to
muscle weakness in OPMD.
Here, we show that transcripts from distal 3′-UTR are retained in
the nuclei in expPABPN1 expressing cells, while transcripts from
internal PAS have a higher cytoplasmic to nuclear ratio. Our
observations are in agreement with a recent study showing
nuclear retention of longer transcript isoforms, while the shorter
transcript isoforms tend to be overrepresented in the cytoplasm.25
Since expPABPN1 has a higher nuclear accumulation,26 it is
possible that the nuclear residence of expPABPN1 and expPABPN1
aggregation in the nucleus lead to nuclear retention of transcripts.
Lower levels of full-length cytoplasmic transcripts could contribute
to alterations in protein levels in the OPMD muscle.
In our previous study, we found that the two canonical
polyadenylation signals are enriched in the distal PAS in the
distal 3′-UTR, and those are less efficiently utilized in expPABPN1-
expressing muscles. Instead the non-canonical motifs in tandem
PAS sites in the distal3′-UTR are utilized in OPMD conditions.9
Here, we extend this observation and show that a shift in PAS
utilization is associated with increased utilization of non-canonical
motifs, although the majority of transcripts from internal PAS are
associated with canonical polyadenylation signal motifs, indicating
that they represent bona fide PASs. The non-canonical AATATA,
GATAAA, AATACA, and AATAGA motifs were more used in A17.1
mouse, whereas the non-canonical AAGAAA motif was found to
be repressed in A17.1 switch regions. Those motifs were not
specifically associated with a switch direction (upstream or
downstream). This suggests that binding of polyadenylation
factors to those motifs is increased in presence of low levels of
PABPN1.
We show alterations in internal PAS utilization in OPMD mouse
and cell models, and the results in muscles were partly replicated
in the muscle cell culture. In muscles expPABPN1 is highly
overexpressed (30-folds),14 whereas in the muscle cell culture the
expPABPN1 overexpression is only 1.3-fold over endogenous
PABPN1 (ref. 13). Additional differences, like different types of
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stress to which the cells and the muscles are exposed, could
contribute to the observed differences between the two models.
These may signify a role for PABPN1 in coordinating the splicing
and polyadenylation machineries, and these may add to the
altered mRNA landscape in OPMD and muscle aging. In conditions
with mutant PABPN1, internal gene PAS utilization affects
transcript identity and its cytoplasmic abundance. The change in
the transcriptome and nuclear export of transcripts could lead to
widespread changes in the proteome. Alternative transcripts of
contractile proteins, like Tnnt3, were indeed found in our switch
analysis. Alteration in those proteins could contribute to muscle
pathology.
MATERIAL AND METHODS
PAS single molecule sequencing method and sequencing
Helicos single-molecule PAS sequencing data were generated
from quadriceps mouse muscles overexpressing the expPABPN1
(A17.1) (ref. 27) and control mice (FBV) aged 6 and 26 weeks (N = 3
per group) as previously described.9 No significant differences in
PAS region usage were found between young (6 weeks) and adult
(26 weeks) mice, therefore, the two age groups were combined (N
= 6). PASs with low counts (<2 reads in<6 samples) were excluded.
The genomic coordinates of mouse PASs (previously assigned and
annotated as described in de Klerk, et al.9) were converted from
genome assembly mm9 to mm10 using the LiftOver utility in
UCSC (http://genome.ucsc.edu). Only 54% of the PASs were found
in genes annotated in Ensembl version 84 (located in 3′-UTRs,
exons, or introns).
Differential expression analysis of genes
Differential expression analysis between A17.1 and FVB control
mice was carried out in R programming language (version 3.2.5).
The analysis was performed on the sum of all reads mapping
between the start and stop coordinates of a gene (on the same
strand) using the R Bioconductor package edge R28 (version
3.14.0). A negative binomial model was fitted and a common and
tag-wise dispersion was estimated for all tags prior testing
procedures. p-values were computed using the exact test and
adjusted for multiple testing using Benjamini and Hochberg’s false
discovery rate.29 In our polyA-sequencing procedure, in contrast to
regular RNA-sequencing, alterations in transcript length do not
affect the number of counts. Gene dysregulation was determined
by normalized counts per gene. Therefore, the definition of gene
dysregulation (expression levels) is independent of transcript
length.
Statistical model to identify genes with PAS utilization changes
between gene regions
PAS counts within each gene region (intron, exon, 3′-UTR) were
summed, and a logistic generalized linear mixed model was fitted
to identify genes with a switch in PAS usage between different
regions within a gene using the R Bioconductor package lme4 (ref.
30). The model for statistical evaluation of differential PAS
ustilization was described in.9 In brief, for each gene with multiple
PAS regions, the counts nij for region j of mouse i were modeled as
binomial using parameters Ni and pij. Here, Ni ¼
Pk
j¼1nij, k is the
number of regions for a particular gene, and Ni is the total number
of reads for all regions of a given gene in mouse i. The log odds of
the parameter pij was modeled using fixed effects for PAS region
and OPMD status, with their interaction, combined with a random
intercept and PAS region effect within a mouse. We tested for the
presence of an OPMD effect with a chi-squared likelihood ratio
test, using as the null hypothesis the same model, but with the
OPMD effect and the OPMD-PAS interaction set to zero. Significant
p-values (FDR < 0.05) indicate genes with a relative change in PAS
usage between different regions in a gene.
To find the direction of the PAS switch, default and switch
region were identified. After adding up the count for all PASs
within a region, default and switch region were defined as regions
with maximum Σ PASFVB—Σ PASA17.1 and minimum Σ PASFVB—Σ
PASA17.1, respectively. With downstream switch we refer to genes
where the default region is located 5′ from the switch region and
with upstream switch we refer to genes where the default region
is located 3′ from the switch region.
Cell culture, RNA isolation, and qRT-PCR
Stable cell cultures of immortalized mouse myoblasts (clone IM2)
over-expressing wild-type (WT) PABPN1 or expPABPN1 are
described in ref. 13. PABPN1 transgene expression is driven by
the Desmin promoter, and was induced by switching proliferating
cultures to fusion conditions using 4% Horse serum in Dulbecco's
modified Eagle medium. Cells were seeded to 80% confluence
and 2 days after incubation with 4% horse serum medium, cells
were collected for RNA isolation.
Total RNA isolation from A17.1 and FBV tibialis anterior mouse
muscles at 18 weeks was carried out as described in de Klerk,
et al.9 cDNA was generated using oligo(dT) and random primer
mix as described in de Klerk, et al.9 qRT-PCR was carried out with
the LightCycler 480 (Roche) using 2× SensiMix reagent (Bioline).
Primers for PAS switches validation in qRT-PCR were designed in
the sequences upstream to the detected PAS (in both default and
switch regions) of six candidate genes. Primers for qRT-PCR were
designed using the Primer3Plus program (version: 2.4.0) (ref. 31).
Primer sequences are listed in Supplementary Table S1. Relative
expression levels of candidate genes were calculated after
normalizing for Hprt housekeeping gene. Ratios between PCR
products were calculated to verify a switch in PAS utilization. Fold
change was calculated after normalization to Hprt FVB control.
Subcellular fractionation in cell culture was carried out as
described in ref. 32 but RNasout® Ribonuclease Inhibitor
(Promega) was added for all extraction and washing buffers.
RNA was isolated from each fraction as described, using the
phenol-chloroform method. Fractionation between the nuclear
and cytoplasmic fractions was verified using western blotting, with
Emerin (nuclear, 1:5000; anti-Rabbit EPR11071, AbCam) and Gapdh
(cytosolic, 1:10,000; anti-mouse G8795, Sigma, Miss. USA). Quality
of RNA from both fractions was assessed using the Bioanalyzer
RNA 6000 Nano kit (Agilent Genomics). Hprt, whose expression
remained unchanged in A17.1, was used for normalization.
Polyadenylation signal motifs analysis
Polyadenylation signal motif analysis was carried out for genes
with a significant switch in PAS utilization. Every read in our data
set marks a specific PAS, and the total number of reads associated
with a specific PAS were used as input in the R Bioconductor
package edgeR to identify the ones that were differentially utilized
between A17.1 and WT mice (as previously described in gene
expression analysis section). Low utilized PASs were defined as
those PASs which were significantly less used in A17.1 compared
with WT mice and high utilized PASs were those which were used
significantly more in A17.1 than WT mice. Only PASs that were low
utilized in default regions and high utilized in switch regions were
considered in genes with upstream and downstream switches.
Thirteen polyadenylation signal motifs were included in the
analysis: 2 canonical and 11 non-canonical, and those motifs were
counted within ~50 nt upstream of all PASs.2 For 24,153 PASs (68%
of all PASs) at least one of the 13 known motifs was found (39,389
motifs in total) and those were included in an analysis assessing
an association with PAS switch. Frequency distribution of motifs in
each group was compared with motif frequencies of all PASs using
Pearson’s chi-squared test. To assess whether the observed
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significant differences differ from random, 1000 random subsets
of PASs for each group were generated and the frequency
distribution of motif in each subset was compared with motif
frequencies of all PASs.
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